Sanovel Pharmaceuticals

Sanovel's foundation was laid by Pharmacist Erol Toksöz in 1983 and it is the first pharmaceutical company with 100% Turkish capital. Sanovel has been operating in the pharmacy sector for over 30 years and today it operates the Turkish pharmaceutical industry into the future with its staff of over 1,200 people and modern production plant.

Sanovel has been known for its dynamism and its structure that is open for improvement, and is a leading company in the pharmaceutical industry with its investments in Human Resources and Research and Development.

The foundation of the new pharmaceutical manufacturing plant of Sanovel İlaç Sanayii Silivri was laid in Çantaköy in November 3, 2001 and it started carry out its business with all its lines as of April 2006. As the new pharmaceutical manufacturing plant, which is equipped with state of the art technologies, started to operate, and the infrastructure activities carried out and investments made for taking part in the international arena have been concluded.

The facility, which was inspected by the German Health Ministry, and given a EU GMP convenience approval in 2009, was later inspected by German (2013) and Spain Health Ministries (2016) and maintains the EU GMP approval. Sanovel, receives approval after the audit conducted between 3 and 11 September 2018 by FDA, the largest health authority in the world. Following this major success, Sanovel İlaç has taken a crucial step towards pharmaceutical export to USA.


As of 2005 it has been carrying out business in the international arena primarily in the Commonwealth of Independent States countries. Some of the countries that it carries out business with in the area are Georgia, Azerbaijan, Kazakhstan, Kyrgyzstan, Uzbekistan, Russia, Ukraine, Iraq, Albania, Turkmenistan.

Sanovel Pharmaceuticals, provides services in fields such as the cardiovascular system, respiratory system, central nervous system, gastrointestinal system, antidiabetic, antiasthmatic, analgesic, antiviral, antifungal, and antibiotics, also veterinary and animal health products.

Sanovel adopts quality as a way of life and gives the utmost importance to medical ethics, aims for perfection in production, respects people and the environment, pays attention to customer satisfaction, and as an innovator it is open to change and improvement, and adopts the principle of being a company that is aware of its corporate and social responsibilities.

Sanovel Pharmaceuticals succeeded in being the first Turkish company to be granted a "patent" from the U.S. Patent Office for four of its medicine formulations. The medicine formulations Sanovel invented via 100% domestic capital are granted with patent protection rights from the USA until 2033.

Sanovel has grown rapidly and consistently since its foundation, and adds value to the sector by giving high importance to Research and Development studies and carries out its business as one of the biggest pharmaceutical companies in the Turkish pharmaceutical industry in terms of turnover.